Established in 2020, the Melbourne ME/CFS Collaboration is directed by Christopher W. Armstrong, PhD.
The Melbourne ME/CFS Research Collaboration seeks to develop a disease management and treatment approach that focuses on the individual patient and the biology that underlies their disease. Their research will look for unifying biological pathways of ME/CFS that cause the disease experience to be the same between patients while also identifying biological aspects that produce different disease experiences between patients.
Chris Armstrong, PhD, is most well known for his research using metabolomics to observe biochemical alterations in ME / CFS patients. He began his work in this field at the University of Melbourne, beginning a PhD project to apply metabolomics to study Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) and published his first ME / CFS metabolomics study on blood and urine in 2015.
Since then Chris has set up collaborative efforts to apply metabolomics to immunological experiments on ME / CFS, observing how metabolism may relate to immune cell function. He has also focused on longitudinal research in ME / CFS while looking to extend metabolic capabilities across the field of ME / CFS to help collate different patient groups.
Nitrogen Metabolism and Testing Nitrogen Hypothesis in ME/CFS STUDY AIM This project aims to test the nitrogen hypothesis, which is that damaging, nitrogen-containing by-products of …
Pediatrics ME/CFS Deep Omics Profiling and Longitudinal Study STUDY AIM This proposal seeks to understand pathological mechanisms of paediatric ME/CFS (13 to 18 years old) …
Characterizing B cells in ME/CFS STUDY AIM This study aims to broadly evaluate B cell subsets, metabolism, viability, receptors, and antibodies in people with ME/CFS. …
Developing Condensed Precision Medicine Protocol for ME/CFS PROTOCOL AIM Establish a condensed personalized research protocol that can be used to characterize ME/CFS in individual patients …
Developing Rapid System for Outlier Analysis in ME/CFS PROTOCOL AIM Establish an analytical workflow for outlier analysis in ME/CFS to identify disease or symptom exacerbators …
To carry out these ambitious projects, Dr. Armstrong is establishing networks and collaborations extending to USA, UK, Sweden, and other Australian institutions.
Christopher Armstrong, PhD
Paul Gooley, PhD
Neil McGregor, PhD
David Ascher, PhD
Elisha Josev, PhD
Sarah Knight, PhD
Adam Scheinberg, MD
David Stroud, PhD
Ronald Davis, PhD
Robert Phair, PhD
Laurel Crosby, PhD
Julie Wilhelmy
Amit Saha, PhD
Layla Cervantes
Anna Okumu
Mike Snyder, PhD
Jonas Bergquist, MD, PhD
Ronald Tompkins, MD, ScD
Wenzhong Xiao, PhD
Michael VanElzakker, PhD
Alain Moreau, PhD
Linda Tannenbaum
Robert Naviaux, MD, PhD
Jarred Younger, PhD
Jo Cambridge, PhD
Sarah Annesley, PhD
Paul Fisher, PhD
Daniel Missailidis
